Last reviewed 2026-04-20 · How we verify

Oxynorm via PCA

Helsinki University Central Hospital · FDA-approved active Small molecule Quality 2/100

Oxynorm via PCA is a Small molecule drug developed by Helsinki University Central Hospital. It is currently FDA-approved.

Oxynorm, administered via patient-controlled analgesia (PCA), is a marketed product by Helsinki University Central Hospital. The key composition patent for Oxynorm is set to expire in 2028, providing a clear timeline for potential generic competition. The primary risk is the loss of exclusivity post-2028, which could significantly impact revenue.

At a glance

Generic name	Oxynorm via PCA
Sponsor	Helsinki University Central Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pain and Medical Abortion Among Teenaged Women Compared to Adult Women (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oxynorm via PCA CI brief — competitive landscape report
Oxynorm via PCA updates RSS · CI watch RSS
Helsinki University Central Hospital portfolio CI

Frequently asked questions about Oxynorm via PCA

What is Oxynorm via PCA?

Oxynorm via PCA is a Small molecule drug developed by Helsinki University Central Hospital.

Who makes Oxynorm via PCA?

Oxynorm via PCA is developed and marketed by Helsinki University Central Hospital (see full Helsinki University Central Hospital pipeline at /company/helsinki-university-central-hospital).

What development phase is Oxynorm via PCA in?

Oxynorm via PCA is FDA-approved (marketed).

Manufacturer: Helsinki University Central Hospital — full pipeline

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing